# Latisha D. Heinlen, M.D. – FDA Inspection, Apr 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/latisha-d-heinlen-md/5e4ef54b-211f-4087-9acb-725d1fafbd01
Source feed: FDA_Inspections

> FDA inspection 1203143 of Latisha D. Heinlen, M.D., April 13, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1203143
- Company Name: Latisha D. Heinlen, M.D.
- Inspection Date: 2023-04-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/chelsea-w-lamm/d7a8dd67-dc26-4c8a-8e3c-aebc267cb775)
- [Company Rep](https://www.keypedia.com/people/corrine-m-carter/69e1be8c-1cd9-48d9-a08e-bf49060b94d6)

Company: https://www.keypedia.com/companies/latisha-d-heinlen-md/d0b88558-186c-4537-9f7e-45a39f7d3426

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c